The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
PRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will present new preclinical and translational ...
Zynlonta is positioned as a single-agent drug approved in third-line DLBCL, with a focus on academic centers for its utilization. Upcoming data from the LOTIS-5 and LOTIS-7 studies could significantly ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana Therapeutics, Inc., a biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its proprietary ...
DAEJEON, South Korea, June 10, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170), a leading biopharmaceutical company specializing in platform technologies, announced today that it presented ...
With groundbreaking clinical impact of traditional ADCs in first-line metastatic indications and ambitions set on neoadjuvant settings, the new era of ADCs are starting to enter the clinic and attract ...
Robert Brooks will outline the clinical progress, commercial potential and global development strategy for Radiance’s lead asset, RB-601 — the first in class bispecific nano ADC engineered to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results